However, the pathology result of the pericardium ... Primary pericardial mesothelioma (PPM) originates from the mesothelial cells of the pericardium. It constitutes less than 1% of all malignant ...

Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I ...

Chemotherapy with pemetrexed and cisplatin (or carboplatin) has become the preferred first-line treatment of malignant pleural mesothelioma based on a randomized Phase III study. Vinorelbine has ...

See complete disclaimer in Appendix 1 and 2 (online only) for more. ASCO convened an Expert Panel of medical oncology, thoracic surgery, radiation oncology, pathology, cancer genetics, and advocacy ...

Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with poor prognosis, and understanding the ...

This protein, called the chimeric antigen receptor or CAR, is what gives these engineered cells such potency against certain cancers and allows them to recognize and destroy malignant cells.

Given the patient’s history of exposure to asbestos-related materials, the combination of epidemiological data and radiological findings strongly indicated a diagnosis of malignant mesothelioma ...

Mesothelioma settlements can be instrumental in helping families maintain financial stability after a diagnosis, cover the costs of treatment, and hold negligent companies accountable. As a national ...

Jan. 31, 2025 — Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders -- T cells -- lose their ability to ...

Cancer therapies do not always succeed in eliminating tumor cells. Some of these cells enter a state of senescence—a latent, non-dividing state that is generally irreversible. Others ...